143 related articles for article (PubMed ID: 27449261)
41. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
Raynor MC; Carson CC; Pearson MD; Nix JW
Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
[TBL] [Abstract][Full Text] [Related]
42. Intermittent hormonal therapy for prostate cancer.
da Silva FC
Curr Opin Urol; 2011 May; 21(3):248-51. PubMed ID: 21427583
[TBL] [Abstract][Full Text] [Related]
43. Testosterone replacement therapy and prostate cancer.
Morgentaler A
Urol Clin North Am; 2007 Nov; 34(4):555-63, vii. PubMed ID: 17983895
[TBL] [Abstract][Full Text] [Related]
44. Prostate cancer risk in testosterone-treated men.
Raynaud JP
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
[TBL] [Abstract][Full Text] [Related]
45. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
46. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Verit A
Int J Impot Res; 2006; 18(6):574; author reply 575. PubMed ID: 17075587
[No Abstract] [Full Text] [Related]
47. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
McGill JJ; Shoskes DA; Sabanegh ES
Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
[TBL] [Abstract][Full Text] [Related]
48. Testosterone and prostate cancer: revisiting old paradigms.
Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
[TBL] [Abstract][Full Text] [Related]
49. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
50. Researchers probe consequences of androgen deprivation for prostate cancer.
Friedrich MJ
JAMA; 2006 Nov; 296(19):2305-6. PubMed ID: 17105787
[No Abstract] [Full Text] [Related]
51. The andrologist's contribution to a better life for ageing men: part 1.
Comhaire F; Mahmoud A
Andrologia; 2016 Feb; 48(1):87-98. PubMed ID: 26395199
[TBL] [Abstract][Full Text] [Related]
52. Testosterone deficiency in men with heart failure: pathophysiology and its clinical, prognostic and therapeutic implications.
Jankowska EA; Tkaczyszyn M; Kalicińska E; Banasiak W; Ponikowski P
Kardiol Pol; 2014; 72(5):403-9. PubMed ID: 24526551
[No Abstract] [Full Text] [Related]
53. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
Kaufman J
Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
[TBL] [Abstract][Full Text] [Related]
54. Is testosterone therapy safe? Take a breath before you take the plunge. Understand the potential risks and consider alternatives before boosting your hormones indefinitely.
Harv Mens Health Watch; 2014 Feb; 18(7):1, 7. PubMed ID: 24818282
[No Abstract] [Full Text] [Related]
55. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
[TBL] [Abstract][Full Text] [Related]
56. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men.
Lašaitė L; Čeponis J; Preikša RT; Žilaitienė B
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27545990
[TBL] [Abstract][Full Text] [Related]
57. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish A
Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
[TBL] [Abstract][Full Text] [Related]
58. Testosterone replacement therapy in hypogonadal men and prostate cancer risk.
Kirby R; Gould D
BJU Int; 2005 Sep; 96(4):471-2. PubMed ID: 16104891
[No Abstract] [Full Text] [Related]
59. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
60. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
